← All organizations
Highest phase reached
Phase 4
Timeline
2010s
- Jul 1, 2012
Aclaris Therapeutics, Inc.— Founded
- Aug 8, 2017
Confluence Life Sciences— Acquired
- Dec 14, 2017
acetaminophen— NDA Secondary Org
Drugs by trial phase (31 distinct, 36 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07011706Lead sponsorPhase 2May 30, 2025
- NCT06648434CollaboratorPhase 1Dec 31, 2024
- NCT06374459CollaboratorPhase 1/Phase 2Nov 30, 2024
- NCT06585202OfficialPhase 2Aug 19, 2024
- NCT06585202Lead sponsorPhase 2Aug 19, 2024
- NCT05791474CollaboratorPhase 1Nov 15, 2023
- NCT05511519Lead sponsorPhase 2Jul 12, 2022
- NCT05432596Lead sponsorPhase 2May 11, 2022
- NCT05279417Lead sponsorPhase 2Feb 2, 2022
- NCT05279417Study directorPhase 2Feb 2, 2022
- NCT05216224Study directorPhase 2Dec 29, 2021
- NCT05216224Lead sponsorPhase 2Dec 29, 2021
- NCT04524858Lead sponsorPhase 2Oct 23, 2020
- NCT04524858Study directorPhase 2Oct 23, 2020
- NCT04598269Lead sponsorPhase 2Sep 30, 2020
Details
- Founded
- Wayne, PA, US Jul 1, 2012
- Last known activity
- May 30, 2025